Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 14, 2020
Reporting Period: The filing reports on the Annual Meeting of Stockholders held on May 12, 2020, and references the issuance of a press release regarding financial results for the quarter ended March 31, 2020.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Item 2.02 states that financial results for the quarter ended March 31, 2020, were announced via a press release furnished as Exhibit 99.1, but the content of that exhibit is not included in the source text.
Material Changes and Corporate Actions
The filing details the certified voting results from the Annual Meeting of Stockholders held on May 12, 2020. Key outcomes include:
- Board Elections: Seven directors were elected to serve until the next annual meeting.
- Accounting Firm: Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Reverse Stock Split: Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split by a ratio not to exceed 1-for-20.
- Equity Plan: Approval to increase the number of shares available for issuance under the 2018 Equity Incentive Plan.
- Executive Compensation: Approval of the non-binding advisory vote on Named Executive Officer compensation.
Guidance, Outlook, and Risks
The filing text does not provide specific management commentary, forward-looking guidance, risk factors, or contingencies. It serves primarily as a notification of the stockholder vote results and the release of Q1 2020 financial data (which is referenced but not detailed in this text).
Investor Verification Checklist
- Verify the specific financial results for the quarter ended March 31, 2020, by reviewing the press release (Exhibit 99.1) referenced in Item 2.02.
- Confirm the implementation timeline and exact ratio of the approved reverse stock split (up to 1-for-20).
- Review the updated share count available under the amended 2018 Equity Incentive Plan.
- Monitor the company's liquidity position given the approval of a reverse stock split, which often indicates efforts to meet listing requirements.